NEIL GARRY ARTHUR 4
4 · Avalo Therapeutics, Inc. · Filed Jun 13, 2023
Insider Transaction Report
Form 4
NEIL GARRY ARTHUR
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2023-06-09$3.42/sh+4,000$13,680→ 13,220 total
Footnotes (1)
- [F1]These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.